CytoMed Therapeutics Limited Adjustments For Increase Decrease In Trade Account Payable
CytoMed Therapeutics Limited (GDTC) reported Adjustments For Increase Decrease In Trade Account Payable of -SGD 170 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2026-03-31
SGD
| Period end | Adjustments For Increase Decrease In Trade Account Payable 12 month | Adjustments For Increase Decrease In Trade Account Payable 12 month as first filed |
|---|---|---|
| 2025-12-31 | -170.00 SGD 20-F · filed 2026-03-31 | |
| 2024-12-31 | -83.60K SGD 20-F · filed 2026-03-31 | |
| 2023-12-31 | 108.22K SGD 20-F · filed 2026-03-31 | 110.18K SGD 20-F · filed 2024-04-22 |
| 2022-12-31 | 265.06K SGD 20-F · filed 2025-04-28 | 255.07K SGD 20-F · filed 2023-05-01 |
| 2021-12-31 | 63.87K SGD 20-F · filed 2024-04-22 | |
| 2020-12-31 | 277.64K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|
| 2025-12-31 | -$132.00 20-F · filed 2026-03-31 |
| 2024-12-31 | -$61.19K 20-F · filed 2025-04-28 |
| 2023-12-31 | $83.51K 20-F · filed 2024-04-22 |
| 2022-12-31 | $190.29K 20-F · filed 2023-05-01 |